/BLAB.CN

BLAB.CN Stock - Britannia Life Sciences Inc.

Q: What is the analyst price target for BLAB.CN?

Analyst price target information is not currently available for BLAB.CN.

Q: What is BLAB.CN's market cap?

Market capitalization information is not currently available for BLAB.CN.

Healthcare|Biotechnology|CNQ

$0.09+0.00%

+$0.00 (+0.00%) • Dec 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.09

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for BLAB.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.11

52W High$0.14

52W Low$0.05

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$369,279	$7.57M	$6.40M	$7.30M	$1.42M
Gross Profit	$27,328	$4.85M	$4.64M	$5.26M	$1.17M
Gross Margin	7.4%	64.1%	72.4%	72.1%	82.2%
Operating Income	$-2,249,945	$173,000	$177,744	$379,567	$114,828
Net Income	$7.39M	$-4,767,808	$5.08M	$-15,458,332	$-157,162
Net Margin	2002.0%	-63.0%	79.4%	-211.8%	-11.0%
EPS	$-0.03	$-0.03	$0.03	$-0.14	$-0.00

Company Overview

Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is based in Toronto, Canada.

Visit Website

Earnings History & Surprises

BLAB.CN

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$0.00

Q4 2023

EPS Surprise History

Q1 21

No data

Q2 21

No data

Q3 22

No data

Q4 22

No data

Q1 23

No data

Q2 23

No data

Q3 23

No data

Q4 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Dec 31, 2023	—	$0.00	—	—
Q3 2023	Sep 30, 2023	—	$0.00	—	—
Q2 2023	Jun 30, 2023	—	$0.03	—	—
Q1 2023	Mar 31, 2023	—	$0.00	—	—
Q4 2022	Dec 31, 2022	—	$-0.00	—	—
Q3 2022	Sep 30, 2022	—	$0.01	—	—
Q2 2021	Jun 30, 2021	—	$0.01	—	—
Q1 2021	Mar 31, 2021	—	$0.00	—	—
Q4 2020	Dec 31, 2020	—	$-0.00	—	—
Q3 2020	Sep 30, 2020	—	$-0.00	—	—

Frequently Asked Questions about BLAB.CN

What is BLAB.CN's current stock price?

Britannia Life Sciences Inc. (BLAB.CN) is currently trading at $0.09 per share. The stock has moved +0.00% today.

What is the analyst price target for BLAB.CN?

No analyst price targets are currently available for this stock.

What sector is Britannia Life Sciences Inc. in?

Britannia Life Sciences Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CNQ exchange.

What is BLAB.CN's market cap?

Britannia Life Sciences Inc. has a market capitalization of $0.01 billion, making it a small-cap company.

Does BLAB.CN pay dividends?

No, Britannia Life Sciences Inc. does not currently pay a dividend to shareholders.